nintedanib
| Full Name | nintedanib |
| Drug | nintedanib |
| Manufacturer | Generic |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | Indicated in adults for: • Treatment of idiopathic pulmonary fibrosis (IPF) • Treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype |
| Disease | Idiopathic Pulmonary Fibrosis (IPF); Chronic Fibrosing Interstitial Lung Diseases (ILDs) |
| Therapeutic Area | Pulmonology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-373-1452 |
| Fax Number | 888-975-1456 |
| Patient Resources |